THE IMPLICATIONS OF USING A 30-, 60-, OR 90-DAY GAP IN TREATMENT TO SPECIFY LINES OF CARE IN GASTRIC CANCER TREATMENT
Abstract
Authors
B Seal KM Shermock CV Asche C Kreilick F Xia J Kish EA Zagadailov M Eaddy
B Seal KM Shermock CV Asche C Kreilick F Xia J Kish EA Zagadailov M Eaddy
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now